- Home
- TXMD vs NUAI Comparison
TXMD vs NUAI Comparison
Compare TXMD & NUAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- NUAI
- Stock Information
- Founded
- TXMD 2008
- NUAI N/A
- Country
- TXMD United States
- NUAI United States
- Employees
- TXMD N/A
- NUAI N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- NUAI Oil & Gas Production
- Sector
- TXMD Health Care
- NUAI Energy
- Exchange
- TXMD Nasdaq
- NUAI Nasdaq
- Market Cap
- TXMD 12.3M
- NUAI 10.4M
- IPO Year
- TXMD N/A
- NUAI N/A
- Fundamental
- Price
- TXMD $1.23
- NUAI $5.41
- Analyst Decision
- TXMD
- NUAI
- Analyst Count
- TXMD 0
- NUAI 0
- Target Price
- TXMD N/A
- NUAI N/A
- AVG Volume (30 Days)
- TXMD 506.6K
- NUAI 31.8M
- Earning Date
- TXMD 11-12-2025
- NUAI 11-14-2025
- Dividend Yield
- TXMD N/A
- NUAI N/A
- EPS Growth
- TXMD N/A
- NUAI N/A
- EPS
- TXMD N/A
- NUAI N/A
- Revenue
- TXMD $2,559,000.00
- NUAI $718,761.00
- Revenue This Year
- TXMD $427.09
- NUAI N/A
- Revenue Next Year
- TXMD N/A
- NUAI N/A
- P/E Ratio
- TXMD N/A
- NUAI N/A
- Revenue Growth
- TXMD 156.93
- NUAI 14.80
- 52 Week Low
- TXMD $0.70
- NUAI $0.32
- 52 Week High
- TXMD $2.44
- NUAI $12.29
- Technical
- Relative Strength Index (RSI)
- TXMD 59.44
- NUAI 64.81
- Support Level
- TXMD $1.20
- NUAI $3.63
- Resistance Level
- TXMD $1.37
- NUAI $6.71
- Average True Range (ATR)
- TXMD 0.12
- NUAI 1.09
- MACD
- TXMD 0.02
- NUAI 0.17
- Stochastic Oscillator
- TXMD 29.85
- NUAI 71.36
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About NUAI New Era Energy & Digital Inc. Common Stock
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.